Abstract Objective To investigate the values of combination of urinary liver-type fatty acid-binding protein (L-FABP) and neutrophil gelatinase-associated lipocalin (NGAL) in early diagnosis of acute kidney injury (AKI) after cardiac surgery in children. Methods A total of 97 children with congenital heart disease undergoing cardiopulmonary bypass surgery were enrolled. Serum and urine samples were collected before and after surgery. Levels of serum creatinine (Scr), urinary L-FABP, and urinary NGAL from AKI group (n=18) and non-AKI group (n=79) were measured, and the postoperative dynamic changes in these markers were compared between the two groups. The receiver operating characteristic (ROC) curve and the area under ROC curve (AUC) were used to assess the values of these markers alone or in combination in the prediction of postoperative AKI. Results The levels of urinary L-FABP and NGAL in the AKI group were signifcantly higher than those in the non-AKI group at 2 and 6 hours after surgery, and the changes in their concentrations were earlier than Scr. The AUCs of urinary L-FABP alone in predicting AKI at 2 and 6 hours after surgery were 0.921 and 0.896 respectively, and those of urinary NGAL alone were 0.908 and 0.928 respectively. Those of their combination were 0.942 and 0.929 respectively. Conclusions Urinary L-FABP and NGAL signifcantly increase in the early stage of AKI after cardiac surgery in children, which are signifcantly earlier than the changes in Scr. They can be used to predict the occurrence of AKI in the early stage. A combination of the two biomarkers can further improve the accuracy of diagnosis.
TANG Rong,AO Xiang,ZHONG Yong et al. Values of combination of urinary L-FABP and NGAL in early diagnosis of acute kidney injury after cardiac surgery in children[J]. CJCP, 2017, 19(7): 770-775.
TANG Rong,AO Xiang,ZHONG Yong et al. Values of combination of urinary L-FABP and NGAL in early diagnosis of acute kidney injury after cardiac surgery in children[J]. CJCP, 2017, 19(7): 770-775.
Hoffman JI, Kaplan S. The incidence of congenital heart disease[J]. J Am Coll Cardiol, 2002, 39(12):1890-1900.
[2]
Miliaresis C, Beker S, Gewitz M. Cardiopulmonary stress testing in children and adults with congenital heart disease[J]. Cardiol Rev, 2014, 22(6):275-278.
[3]
Li S, Krawczeski CD, Zappitelli M, et al. TRIBE-AKI Consortium. Incidence, risk factors, and outcomes of acute kidney injury after pediatric cardiac surgery:a prospective multicenter study[J]. Crit Care Med, 2011, 39(6):1493-1499.
[4]
Sethi SK, Goyal D, Yadav DK, et al. Predictors of acute kidney injury post-cardiopulmonary bypass in children[J]. Clin Exp Nephrol, 2011, 15(4):529-534.
[5]
Ronco C. Biomarkers for acute kidney injury:is NGAL ready for clinical use?[J]. Crit Care, 2014, 18(6):680.
[6]
Paikh CR, Thiessen-Philbrook H, Garg AX, et al. TRIBE-AKI Consortium. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery[J]. Clin J Am Soc Nephrol, 2013, 8(7):1079-1088.
[7]
Zappitelli M, Greenberg JH, Coca SG, et al. Association of definition of acute kidney injury by cystatin C rise with biomarkers and clinical outcomes in children undergoing cardiac surgery[J]. JAMA Pediatr, 2015, 169(6):583-591.
[8]
Prowle JR, Calzavacca P, Licari E, et al. Combination of biomarkers for diagnosis of acute kidney injury after cardiopulmonary bypass[J]. Ren Fail, 2015, 37(3):408-416.
[9]
Portilla D, Dent C, Sugaya T, et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery[J]. Kidney Int, 2008, 73(4):465-472.
[10]
Han WK, Wagener G, Zhu Y, et al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery[J]. Clin J Am Soc Nephrol, 2009, 4(5):873-882.
[11]
Beger RD, Holland RD, Sun J, et al. Metabonomics of acute kidney injury in children after cardiac surgery[J]. Pediatr Nephrol, 2008, 23(6):977-984.
[12]
Thomas ME, Blaine C, Dawnay A, et al. The defnition of acute kidney injury and its use in practice[J]. Kidney Int, 2015, 87(1):62-73.
[13]
Thumser AE, Moore JB, Plant NJ. Fatty acid binding proteins:tissue-specifc functions in health and disease[J]. Curr Opin Clin Nutr Metab Care, 2014, 17(2):124-129.
[14]
Martin GG, Atshaves BP, McIntosh AL, et al. Liver fatty-acidbinding protein (L-FABP) gene ablation alters liver bile acid metabolism in male mice[J]. Biochem J, 2005, 391(Pt 3):549-560.
[15]
McMahon BA, Murray PT. Urinary liver fatty acid-binding protein:another novel biomarker of acute kidney injury[J]. Kidney Int, 2010, 77(8):657-659.
[16]
Przybylowski P, Koc-Zorawska E, Malyszko JS, et al. Liver fatty-acid-binding protein in heart and kidney allograft recipients in relation to kidney function[J]. Transplant Proc, 2011, 43(8):3064-3067.
[17]
Doi K, Noiri E, Sugaya T. Urinary L-type fatty acid-binding protein as a new renal biomarker in critical care[J]. Curr Opin Crit Care, 2010, 16(6):545-549.
[18]
Manabe K, Kamihata H, Motohiro M, et al. Urinary liver-type fatty acid-binding protein level as a predictive biomarker of contrast-induced acute kidney injury[J]. Eur J Clin Invest, 2012, 42(5):557-563.
[19]
Xu Y, Xie Y, Shao X, et al. L-FABP:A novel biomarker of kidney disease[J]. Clin Chim Act, 2015, 445:85-90.
[20]
Devarajan P. Neutrophil gelatinase-associated lipocalin:a promising biomarker for human acute kidney injury[J]. Biomark Med, 2010, 4(2):265-280.
[21]
Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinaseassociated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery[J]. Lancet, 2005, 365(9466):1231-1238.
[22]
Hjortrup PB, Haase N, Wetterslev M, et al. Clinical review:Predictive value of neutrophil gelatinase-associated lipocalin for acute kidney injury in intensive care patients[J]. Crit Care, 2013, 17(2):211.
[23]
Liangos O, Tighiouart H, Perianayagam MC, et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass[J]. Biomarkers, 2009, 14(6):423-431.
[24]
de Geus HR, Betjes MG, Bakker J. Biomarkers for the prediction of acute kidney injury:a narrative review on current status and future challenges[J]. Clin Kidney J, 2012, 5(2):102-108.